HeartSciences Inc. announced that the University of the West of England (UWE) has adopted the company’s MyoVista Insights™ platform and MyoVista® wavECG™ device as its exclusive ECG technologies. These products will be used to establish an ECG Education and Technology Reference Center at UWE, where they will be integrated into the university’s cardiac and physiological science teaching programs. The agreement aims to support the training of future NHS cardiac scientists and contribute to workforce development in the UK’s cardiac diagnostic sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9649276-en) on February 05, 2026, and is solely responsible for the information contained therein.
Comments